UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by First Horizon Advisors Inc.

First Horizon Advisors Inc. grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 6,585 shares of the healthcare conglomerate’s stock after purchasing an additional 59 shares during the period. First Horizon Advisors Inc.’s holdings in UnitedHealth Group were worth $3,467,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Richelieu Gestion SA bought a new stake in shares of UnitedHealth Group in the 4th quarter worth $26,000. CGC Financial Services LLC boosted its position in shares of UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 50 shares in the last quarter. NewSquare Capital LLC boosted its holdings in UnitedHealth Group by 340.0% during the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 51 shares in the last quarter. LFA Lugano Financial Advisors SA lifted its position in shares of UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after acquiring an additional 40 shares during the last quarter. Finally, O Brien Wealth Partners LLC boosted its stake in shares of UnitedHealth Group by 36.8% during the 4th quarter. O Brien Wealth Partners LLC now owns 78 shares of the healthcare conglomerate’s stock worth $41,000 after acquiring an additional 21 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

Analysts Set New Price Targets

Several analysts have issued reports on the company. HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price objective on the stock in a report on Thursday, April 4th. TD Cowen cut their target price on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th. Bank of America reiterated a “buy” rating and set a $675.00 price target on shares of UnitedHealth Group in a report on Thursday, March 7th. Deutsche Bank Aktiengesellschaft raised their price objective on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research report on Friday, April 19th. Finally, Piper Sandler raised their price target on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. Four analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $570.05.

UnitedHealth Group Stock Down 0.1 %

Shares of NYSE:UNH opened at $492.45 on Friday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The stock has a market cap of $453.09 billion, a price-to-earnings ratio of 30.10, a P/E/G ratio of 1.43 and a beta of 0.55. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The company has a 50 day moving average of $483.02 and a 200-day moving average of $513.07.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm’s revenue was up 8.6% on a year-over-year basis. During the same period last year, the company earned $6.26 EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.53%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 45.97%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.